Status:
COMPLETED
Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation
Lead Sponsor:
AstraZeneca
Conditions:
Bronchial Asthma
Eligibility:
All Genders
Brief Summary
The purpose of this study is to confirm the safety profile for long term treatment in children aged 5 years and \<15 years on bronchial asthma in daily clinical usage/Effect on growth rate. Effect on ...
Eligibility Criteria
Inclusion
- Patients treated with Pulmicort Turbuhaler for the first time due to bronchial asthma and children of \>= 5 years and \< 15 years old age at the start of study treatment
Exclusion
- None
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT01203904
Start Date
September 1 2010
End Date
September 1 2015
Last Update
June 7 2016
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aichi, Japan
2
Research Site
Chiba, Japan
3
Research Site
Ehime, Japan
4
Research Site
Fukui, Japan